2024 annual financial data
Inovio Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was -51,616.91%.
Operating income was -112,398,922 USD and net income was -107,254,126 USD.
Operating cash flow was -104,076,553 USD.
Get free Inovio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 217,756 USD
- Operating income
- -112,398,922 USD
- Net income
- -107,254,126 USD
- Operating cash flow
- -104,076,553 USD